Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$13.9M Sell
404,882
-21,133
-5% -$776K 0.02% 621
2018
Q4
$13.6M Sell
426,015
-34,395
-7% -$1.3M 0.02% 601
2018
Q3
$21.1M Sell
460,410
-23,533
-5% -$1.18M 0.02% 573
2018
Q2
$25.6M Sell
483,943
-17,734
-4% -$943K 0.03% 521
2018
Q1
$25.1M Buy
501,677
+10,001
+2% +$504K 0.03% 506
2017
Q4
$23.6M Buy
491,676
+67,885
+16% +$3.22M 0.03% 532
2017
Q3
$19.5M Buy
423,791
+179,117
+73% +$7.76M 0.02% 573
2017
Q2
$10.8M Buy
244,674
+236,948
+3,067% +$9.96M 0.01% 723
2017
Q1
$317K Buy
7,726
+1,998
+35% +$83.3K ﹤0.01% 1689
2016
Q4
$235K Buy
+5,728
New +$211K ﹤0.01% 1684
2013
Q3
Sell
-889,286
Closed -$18.2M 963
2013
Q2
$18.2M Buy
+889,286
New +$16.8M 0.03% 532

Other funds holding SNV

OppenheimerFunds's SNV Position: Q1 2019 in Review

OppenheimerFunds reduced its Synovus (SNV) stake by 5% in Q1 2019, selling an estimated $776K and leaving 404,882 shares worth $13.9M. The position accounts for 0.02% of the portfolio, ranked #621.

OppenheimerFunds first reported a position in SNV in Q2 2013 and has held it in 11 quarters since. The position peaked at $25.6M in Q2 2018. 385 funds tracked by Wall St. Rank hold SNV as of Q1 2019.

  • OppenheimerFunds held 404,882 shares of Synovus worth $13.9M as of Q1 2019.
  • OppenheimerFunds sold 21,133 Synovus shares in Q1 2019, an estimated $776K.
  • Synovus made up 0.02% of OppenheimerFunds's portfolio in Q1 2019, its #621 holding.
  • OppenheimerFunds first reported a position in Synovus in Q2 2013 and has held it in 11 quarters since.
  • OppenheimerFunds's Synovus position peaked at $25.6M in Q2 2018.
  • 385 funds tracked by Wall St. Rank held Synovus as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.